SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001485003-16-000065
Filing Date
2016-03-24
Accepted
2016-03-24 08:28:47
Documents
3
Period of Report
2016-03-24
Items
Item 2.02: Results of Operations and Financial Condition

Document Format Files

Seq Description Document Type Size
1 8-K ebio-123115x8k.htm 8-K 35369
2 EXHIBIT 99.1 eleven15yereleasefinal.htm EX-99.1 135673
3 ebiologo.jpg GRAPHIC 15878
  Complete submission text file 0001485003-16-000065.txt   194105
Mailing Address 215 FIRST STREET SUITE 400 CAMBRIDGE MA 02142
Business Address 215 FIRST STREET SUITE 400 CAMBRIDGE MA 02142 617-871-9911
Eleven Biotherapeutics, Inc. (Filer) CIK: 0001485003 (see all company filings)

IRS No.: 252025616 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36296 | Film No.: 161525428
SIC: 2834 Pharmaceutical Preparations